Drugs / RPN301
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05337228 Comparator | Aug 2022 → Feb 2023 | parenteral nutrition-associated cholestasis | HK inno.N Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RPN301 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05337228 ↗ |
| Route | Other | “RPN301 will be injected continuously for 3 days.” NCT05337228 ↗ |